pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Cardiology · news · pharmadog
← back to Cardiology
News · Cardiology
591
stories
13d
Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030
biospace
13d
STAT+: Novo may be getting a better deal than expected with Medicare’s Bridge program
stat
13d
2026 IPO blitz continues with 4 new biotech filings
biospace
13d
Novo’s workforce reduction climbs to 13,000 to fuel R&D work
biospace
13d
Roche’s Carmot asset normalizes blood sugar, cuts weight in Phase 2 diabetes trial
biospace
13d
A federal AI experiment could transform chronic care — if doctors and patients want it
endpoints
13d
New federal autism committee head has financial ties to leucovorin
stat
13d
Roche’s GLP-1/GIP drug hits in phase 2 diabetes trial, fueling best-in-disease hopes
fiercebiotech
14d
Global Mix Inc. Recalls Niwali Tejocote Capsules and Niwali Tejocote Pieces Because of Possible Health Risk
fda recalls
14d
Novo talks up drug launches in effort to win back investors
biopharma dive
14d
Novo’s plan to hit $23B in revenue by 2035 leaves investors wanting
biospace
14d
Novo struggles to appease restive investors with consumer plans, blockbuster ambitions
fiercebiotech
14d
Are healthcare systems really ready for GLP-1s?
biopharma dive
14d
Skeptical about modern medicine? I know the feeling — and want to listen
stat
17d
Ultragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drug
biopharma dive
17d
Refreshed Novo corrals 3 new early-stage obesity drugs from Kallyope
fiercebiotech
17d
Opinion: Doctors should educate patients about ‘Asian glow’ and drinking risks
stat
17d
Nitric Oxide Delivery System Correction: NOxBOX Updates Use Instructions for NOxBOXi Nitric Oxide Delivery System
fda medwatch
18d
Lisata deal propels Marea’s drug pipeline to Wall Street
biopharma dive
18d
Definium’s new psychedelics data, and a reprieve for international scientists
stat
18d
Two more biotechs, Marea and North Immunology, do reverse mergers
endpoints
18d
Novo notches up to $1.4B pact with Orbis to develop oral macrocycle cardiometabolic drugs
biospace
18d
Chutes & Ladders—Legend poaches Novartis vet to boost commercial potential
fiercebiotech
18d
Kennedy moves to revive preventive services panel with new members, after months of vacancies
stat
18d
Longeveron’s shares crash as stem cell therapy flunks mid-stage cardio trial
biospace
18d
STAT+: A Sellas immunotherapy study, long delayed, will end in failure
stat
18d
STAT+: A biotech hedge fund births a new immunology company
stat
18d
After one failed acquisition attempt, Lisata finds lifeline in Marea merger
fiercebiotech
18d
Opinion: What happened to oppositional defiant disorder?
stat
18d
STAT+: The FDA’s rebuilding effort is running into a new challenge
stat
← prev
page 3 of 20
next →
